Antiphospholipid syndrome (APS) is a multisystem autoimmune condition characterized by vascular thromboses associated with persistently positive antiphospholipid antibodies. There is currently a paucity of data (incidence, prevalence, thrombosis risk, and effective treatment) in pediatric APS. The purpose of this report is to review the current literature on APS in children and neonates, identify the gaps in current knowledge, and suggest avenues for studies to fill those gaps.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1007/s11926-015-0504-5 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!